SenoRx, Inc. (NASDAQ:SENO)

CAPS Rating: 1 out of 5

The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.

Recs

0
Player Avatar MstrGold (91.48) Submitted: 6/9/2010 6:49:39 AM : Underperform Start Price: $7.03 SENO Score: -43.33

Company is overvalued in terms of fundamental prospects (source Ultralong).

Report this Post Reply

Featured Broker Partners


Advertisement